We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Dorman Products
DORM
$4.18B
| $2.82M | 0.01% |
29,220
+15,695
| +116% | +$1.35M |
|
1227
Global X Silver Miners ETF NEW
SIL
$4.75B
| $2.81M | 0.01% |
102,500
-7,900
| -7% | -$200K |
|
1228
Edison International
EIX
$26.4B
| $2.81M | 0.01% |
39,790
+34,547
| +659% | +$2.36M |
|
1229
Dynatrace
DT
$14.2B
| $2.81M | 0.01% |
60,440
+18,140
| +43% | +$945K |
|
1230
Savara
SVRA
$1.19B
| $2.8M | 0.01% |
562,186
+426,344
| +314% | +$2.06M |
|
1231
Acadia Healthcare
ACHC
$2.94B
| $2.8M | 0.01% |
35,339
+27,417
| +346% | +$2.24M |
|
1232
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
| $2.8M | 0.01% |
72,240
-111,940
| -61% | -$3.87M |
|
1233
Fortuna Silver Mines
FSM
$3.07B
| $2.79M | 0.01% |
749,170
+448,429
| +149% | +$1.44M |
|
1234
KBR
KBR
$4.8B
| $2.79M | 0.01% |
43,884
-1,593
| -4% | -$90.7K |
|
1235
LendingTree
TREE
$451M
| $2.79M | 0.01% |
65,824
-40,971
| -38% | -$1.43M |
|
1236
Albertsons Companies
ACI
$5.83B
| $2.77M | 0.01% |
129,198
+16,998
| +15% | +$365K |
|
|
WCLD
1237
WisdomTree Cloud Computing Fund
WCLD
$297M
| $2.76M | 0.01% |
79,300
-200,800
| -72% | -$7M |
|
1238
Cincinnati Financial
CINF
$27.1B
| $2.75M | 0.01% |
22,118
-26,080
| -54% | -$2.94M |
|
1239
Sutro Biopharma
STRO
$421M
| $2.74M | 0.01% |
48,576
+16,257
| +50% | +$718K |
|
|
INBX
1240
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.74M | 0.01% |
78,400
+70,500
| +892% | +$2.57M |
|
1241
PUT
Virgin Galactic
SPCE
$398M
| $2.73M | 0.01% |
92,320
-2,000
| -2% | -$72.6K |
|
1242
Fresenius Medical Care
FMS
$12.9B
| $2.73M | 0.01% |
141,707
+79,207
| +127% | +$1.57M |
|
1243
Ducommun
DCO
$2.98B
| $2.73M | 0.01% |
53,182
+5,894
| +12% | +$294K |
|
1244
Anavex Life Sciences
AVXL
$310M
| $2.73M | 0.01% |
535,547
+489,046
| +1,052% | +$2.75M |
|
|
LPRO
1245
DELISTED
Open Lending Corp
LPRO
| $2.72M | 0.01% |
433,959
-173,316
| -29% | -$1.28M |
|
1246
SandRidge Energy
SD
$503M
| $2.71M | 0.01% |
186,182
+22,571
| +14% | +$305K |
|
1247
Enviri
NVRI
$620M
| $2.71M | 0.01% |
296,063
-89,991
| -23% | -$756K |
|
1248
AnaptysBio
ANAB
$1.68B
| $2.7M | 0.01% |
119,971
+32,441
| +37% | +$768K |
|
1249
Liberty Global Class A
LBTYA
$3.6B
| $2.7M | 0.01% |
+159,302
| New | +$2.91M |
|
1250
Armstrong World Industries
AWI
$7.84B
| $2.69M | 0.01% |
21,695
-82,115
| -79% | -$9.06M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.